Skip to main content
RLYB logo

Rallybio Corporation

RLYBNASDAQHealthcareBiotechnology

$16.28Today:- (-)1Y +3009.70%

As of Oct 16, 2026 close

Market cap
$96.48M
P/E (TTM)
2.12
Forward P/E
-
Dividend yield
-
52-week range
$0.52$17.57
Volume (live)
-
Avg. volume (3M)
9.40K

Rallybio (RLYB) Income Statement

Rallybio reported revenue of $858.00K in fiscal 2025 (fiscal year ended Dec 31, 2025), up 34.9% from $636.00K a year earlier. Rallybio posted a net loss of $8.98M, compared with a net loss of $57.77M a year earlier. Gross margin was 89.3% and operating margin -3270.9%.

Rallybio Income Statement Analysis

Values in millions USD

Scroll to see more
Rallybio Corporation income statement - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Revenue & Gross Profit
Revenue0.860.640.000.000.000.000.00
Cost of Revenue0.0939.510.150.000.110.060.03
Gross Profit0.77-38.87-0.150.00-0.11-0.06-0.03
Operating Expenses
Research & Development19.6041.5153.5440.6926.9117.6311.37
Selling, General & Administrative14.3319.6325.3927.2018.747.676.28
Operating Expenses28.8361.1378.9367.8845.6525.3017.64
Operating Income-28.06-60.50-78.93-67.88-45.65-25.30-17.64
Other Income/Expense
Interest Income2.194.226.151.960.050.170.20
Interest Expense0.000.000.000.000.010.050.04
Other Income/Expense19.09-1.50-1.781.230.10-1.160.08
Income
Income Before Tax-8.98-57.78-74.56-66.65-45.51-26.46-17.46
Income Tax Expense0.000.000.000.000.00-0.020.00
Net Income-8.98-57.78-74.56-66.65-47.01-26.45-17.63
Net Income - Continuous Operations-8.98-57.78-74.56-66.65-47.01-26.45-17.63
Net Income - Discontinued Operations-------
EBITDA-27.97-60.37-78.78-67.72-45.39-25.24-17.39
EBIT-31.36-60.50-78.93-67.88-45.50-25.30-
Depreciation & Amortization0.090.130.150.170.110.060.03
Earnings Per Share
Basic EPS-2.00-11.00-15.00-17.00-15.00-10.00-4.00
Diluted EPS-2.00-11.00-15.00-17.00-15.00-10.00-6.00
Basic Shares Outstanding5.635.445.063.983.192.782.78
Diluted Shares Outstanding5.635.445.063.983.192.782.78

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Rallybio Financial Statements

What was Rallybio's revenue in fiscal 2025?

Rallybio reported revenue of $858.00K in fiscal 2025 (fiscal year ended Dec 31, 2025). That was up 34.9% from $636.00K a year earlier.

Is Rallybio profitable?

No. Rallybio reported a net loss of $8.98M in fiscal 2025. In fiscal 2024 it lost $57.77M.

What is Rallybio's operating margin?

Rallybio's operating income was −$28.06M on revenue of $858.00K in fiscal 2025, an operating margin of -3270.9%, compared with -9511.9% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition